Citation: Lewis K, Balas MC, Stollings JL, et al. A focused update to the clinical practice guideline for the prevention and management of pain, anxiety, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. In press.
Critically ill adults are at risk for a variety of consequential symptoms both during and after an ICU stay. Management of these symptoms can directly influence outcomes. These SCCM guidelines update and expand on SCCM’s 2018 Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.
The task force issued five statements related to the management of anxiety (new topic), agitation/sedation, delirium, immobility, and sleep disruption in adults the ICU. The task force issued conditional recommendations to use dexmedetomidine over propofol for sedation,
provide enhanced mobilization/rehabilitation over usual mobilization/rehabilitation, and administer melatonin. The task force was unable to issue recommendations on the administration of benzodiazepines to treat anxiety, and the use of antipsychotics to treat delirium.
Guideline Type: Clinical
Related Resources:
![]() |
Visual Abstract: Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU |